Baumer S.A.
BALM3.SA
Get informed when a big investor buys or sells
+ FollowMarket Cap$253.13M
Close$
$26.32
19.6% upside
Current Fair Value
19.6% upsideUndervalued by 19.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $253.13 Million |
|---|---|
| Enterprise Value | $270.46 Million |
| Dividend Yield | $5.32 (21.27%) |
| Earnings per Share | $1.85 |
| Beta | 0.35 |
| Outstanding Shares | 9,784,510 |
Return
| Return on Equity | 13.47% |
|---|---|
| Return on Assets | 7.75% |
| Return on Invested Capital | 19.33% |
Valuation & Multiples
| P/E Ratio | 9.48 |
|---|---|
| PEG | 14.41 |
| Price to Sales | 1.1 |
| Price to Book Ratio | 1.38 |
| Enterprise Value to Revenue | 1.32 |
| Enterprise Value to EBIT | 6.61 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Baumer S.A.
6 employees
CEO: Ruy Baumer Baumer SA engages in the development, manufacture, and sale of hospital, odontology, and health industry solutions and equipment. It operates through the following segments: Orthopedics, Hospital, Genius, and Castanho. The Orthopedics se...